<SEC-DOCUMENT>0001013594-25-000021.txt : 20250108
<SEC-HEADER>0001013594-25-000021.hdr.sgml : 20250108
<ACCEPTANCE-DATETIME>20250108173318
ACCESSION NUMBER:		0001013594-25-000021
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250108

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifeward Ltd.
		CENTRAL INDEX KEY:			0001607962
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88650
		FILM NUMBER:		25519456

	BUSINESS ADDRESS:	
		STREET 1:		200 DONALD LYNCH BLVD.
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		15082511154

	MAIL ADDRESS:	
		STREET 1:		200 DONALD LYNCH BLVD.
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ReWalk Robotics Ltd.
		DATE OF NAME CHANGE:	20140620

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Argo Medical Technologies Ltd.
		DATE OF NAME CHANGE:	20140513

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lind Global Fund II LP
		CENTRAL INDEX KEY:			0001871665
		ORGANIZATION NAME:           	
		IRS NUMBER:				863914253
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		444 MADISON AVENUE
		STREET 2:		41ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		646-701-7428

	MAIL ADDRESS:	
		STREET 1:		444 MADISON AVENUE
		STREET 2:		41ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001871665</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<securitiesClassTitle>Ordinary shares, par value NIS 1.75</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>01/06/2025</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001607962</issuerCik>
<issuerName>Lifeward Ltd.</issuerName>
<issuerCusip>M8216Q200</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>200 DONALD LYNCH BLVD.</com:street1>
<com:city>MARLBOROUGH</com:city>
<com:stateOrCountry>MA</com:stateOrCountry>
<com:zipCode>01752</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Lind Global Fund II LP</reportingPersonName>
<citizenshipOrOrganization>DE</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>945746</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>945746</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>945746</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>8.9</classPercent>
<typeOfReportingPerson>PN</typeOfReportingPerson>
<comments>The reporting person owns warrants to purchase 87,750 Ordinary Shares which are freely exercisable.</comments>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Lind Global Partners II LLC</reportingPersonName>
<citizenshipOrOrganization>DE</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>945746</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>945746</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>945746</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>8.9</classPercent>
<typeOfReportingPerson>OO</typeOfReportingPerson>
<comments>The reporting person may be deemed to beneficially own warrants to purchase 87,750 Ordinary Shares which are freely exercisable.</comments>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>EASTON JEFF</reportingPersonName>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>945746</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>945746</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>945746</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>8.9</classPercent>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<comments>The reporting person may be deemed to beneficially own warrants to purchase 87,750 Ordinary Shares which are freely exercisable.</comments>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>Lifeward Ltd.</issuerName>
<issuerPrincipalExecutiveOfficeAddress>200 DONALD LYNCH BLVD., MARLBOROUGH, Massachusetts, 01752</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>Lind Global Fund II LP, a Delaware limited partnership ("Global Fund");&#13;
&#13;
Lind Global Partners II LLC, a Delaware limited liability company ("Global Partners II"); and&#13;
&#13;
Jeff Easton, a citizen of the United States of America ("Mr. Easton").</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>The principal business address of each of the Reporting Persons is 444 Madison Ave., 41st Floor, New York, NY 10022.</principalBusinessOfficeOrResidenceAddress>
<citizenship>Please see disclosure in Item 2(a).</citizenship>
</item2>
<item3>
<notApplicableFlag>Y</notApplicableFlag>
</item3>
<item4>
<amountBeneficiallyOwned>As of January 8, 2025, Global Fund beneficially owned  945,746 Ordinary Shares (including 87,750 Ordinary Shares issuable upon the exercise of certain warrants held by Global Fund, which warrants are freely exercisable).&#13;
&#13;
Global Partners II, as the general partner of Global Fund, may be deemed to have beneficially owned the  945,746 Ordinary Shares beneficially owned by Global Fund. &#13;
&#13;
Mr. Easton, as the Managing Member of Global Partners II, may be deemed to have beneficially owned the  945,746 Ordinary Shares beneficially owned by Global Partners II.</amountBeneficiallyOwned>
<classPercent>The aggregate percentage of Ordinary Shares reported owned by each reporting person named herein is based upon 10,626,799 Ordinary Shares outstanding as of January 8, 2025, which is the sum of (i) 8,808,616 Ordinary Shares outstanding as of January 8, 2025, as disclosed in the Issuer's Prospectus Supplement filed pursuant to Rule 424(b)(5) with Registration No. 333-263984, filed with the Securities and Exchange Commission on January 8, 2025, plus (ii) 1,818,183 Ordinary Shares issued by the Issuer on January 8, 2025, as disclosed in the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on January 8, 2025.&#13;
&#13;
As of January 8, 2025, the Reporting Persons may be deemed to have beneficially owned approximately the following percentage of the outstanding Ordinary Shares: 8.9</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>See Cover Pages Items 5-8.</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>See Cover Pages Items 5-8.</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>See Cover Pages Items 5-8.</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>See Cover Pages Items 5-8.</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>Y</notApplicableFlag>
</item5>
<item6>
<notApplicableFlag>Y</notApplicableFlag>
</item6>
<item7>
<notApplicableFlag>Y</notApplicableFlag>
</item7>
<item8>
<notApplicableFlag>N</notApplicableFlag>
<identificationAndClassificationOfGroupMembers>See Exhibit 99.2 to the Schedule 13G filed by the Reporting Persons on October 4, 2021.</identificationAndClassificationOfGroupMembers>
</item8>
<item9>
<notApplicableFlag>Y</notApplicableFlag>
</item9>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<signatureInformation>
<reportingPersonName>Lind Global Fund II LP</reportingPersonName>
<signatureDetails>
<signature>By: Lind Global Partners II LLC,</signature>
<title>/s/ Jeff Easton, Managing Member</title>
<date>01/08/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>Lind Global Partners II LLC</reportingPersonName>
<signatureDetails>
<signature>/s/ Jeff Easton</signature>
<title>Jeff Easton, Managing Member</title>
<date>01/08/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>EASTON JEFF</reportingPersonName>
<signatureDetails>
<signature>/s/ Jeff Easton</signature>
<title>EASTON JEFF</title>
<date>01/08/2025</date>
</signatureDetails>
</signatureInformation>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
